Take Surge Pricing to the Limit. Then Go Further.

Dezenhall Resources / October 9, 2015
Read full Substack

The New York Times’ John Schwartz asks Eric Dezenhall about why Martin Shkreli the Turing Pharmaceutical executive who raised its drug Daraprim price to $750 a pill from $13.50 was vilified so quickly. Read the article for Eric’s simple answer.

A logo features a hexagon divided into six triangular sections, each in varying shades of gray. The word "dez" is centered within the hexagon and written in lowercase letters.
AUTHOR: Dezenhall Resources
Dez Reads. Scamming the Scammers.
Dezenhall Resources December 13, 2024

There are few people I hold in lower regard than scammers, especially those who take advantage of the elderly and vulnerable. Around the time my parents retired, I started policing…
Dez Reads. Buy Eric’s Book
Dezenhall Resources December 6, 2024

We cover everything from the top cultural conversation – Annie Moore writes on the ubiquitousness of Wicked – and some other stories that deserve more conversation, like David Manitsky’s take…
Dez Reads. Who’s Headed to Bluesky?
Dezenhall Resources November 22, 2024

We’re back! Washington is in full-on gossip mode around the presidential transition and the new Congress. We speak of none of that here at Dez Reads. I am interested in…